These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 31158304)
1. Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors. Adachi Y; Nojima M; Mori M; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; J Gastroenterol Hepatol; 2019 Dec; 34(12):2104-2111. PubMed ID: 31158304 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study. Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study. Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A; Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study. Adachi Y; Nojima M; Mori M; Yamashita K; Yamano HO; Nakase H; Endo T; Wakai K; Sakata K; Tamakoshi A World J Gastroenterol; 2017 May; 23(19):3488-3495. PubMed ID: 28596684 [TBL] [Abstract][Full Text] [Related]
5. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074 [TBL] [Abstract][Full Text] [Related]
6. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1. Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. ; Key TJ; Appleby PN; Reeves GK; Roddam AW Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501 [TBL] [Abstract][Full Text] [Related]
8. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan. Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A; Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083 [TBL] [Abstract][Full Text] [Related]
10. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922 [TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study. Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082 [TBL] [Abstract][Full Text] [Related]
12. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study. Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A; Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081 [TBL] [Abstract][Full Text] [Related]
14. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654 [TBL] [Abstract][Full Text] [Related]
15. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study. Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090 [TBL] [Abstract][Full Text] [Related]
17. Lack of association between risk of biliary tract cancer and circulating IGF (Insulin-like Growth Factor) -I, IGF-II or IGFBP-3 (IGF-binding Protein-3): A nested case-control study in a large scale cohort study in Japan. Yagyu K; Kikuchi S; Lin Y; Ishibashi T; Obata Y; Kurosawa M; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A; Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():63-7. PubMed ID: 20553084 [TBL] [Abstract][Full Text] [Related]
18. Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis. Rainato G; Fabricio AS; Zancan M; Peloso L; Dittadi R; Barichello M; Fandella A; Scattoni V; Gion M Int J Biol Markers; 2016 Jul; 31(3):e317-23. PubMed ID: 26954072 [TBL] [Abstract][Full Text] [Related]
19. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]